Analysis of Complement Factor H Gene Polymorphisms and Their Association with Clinical Manifestations Ofleptospirosis

Overview

Journal Immunogenetics

Specialties Allergy & Immunology
Genetics

Date 2024 Nov 30

PMID 39614881

Authors

Lazara Elena Santiesteban-Lores

Leonardo Moura Midon

ThirsaAlvares Franco

Luciano Marcondes de Oliveira

Sumire Hibi

Yosena Chiani

GdayllonCavalcante Meneses

Elizabeth De Francesco Daher

Denise Moraes Fonseca

Alessandra Pontillo

Lourdes Isaac

Affiliations

Soon will be listed here.

Abstract

Leptospirosis is caused by pathogenic leptospires, posing a significant public health problem. Host susceptibility to Leptospira infection is a multifactorial trait, and the host's genetic background can influence both the establishment of infection and the severity of the disease. Complement Factor H (FH) plays a crucial role in the interaction between pathogenic bacteria and the host. Genetic variants in the FH gene CFH have previously been associated with non-infectious diseases. Here, we aimed to analyze the effect of CFH variants on individual susceptibility to leptospirosis and disease severity. To accomplish this, we sequenced CFH exons 7, 9, 21, 22, and 23 in a case/control cohort (184/162) from two endemic leptospirosis areas in Brazil and Argentina. We identified twenty-one single nucleotide variants (SNVs). In the Brazilian cohort, the intronic variant rs34815383 exhibited a higher frequency in patients than in controls, resulting in a significant association with leptospirosis (p = 0.032; OR: 0.32; 95% CI 0.1-1) and also renal disorder (p = 0.001; OR: 5.3; 95%CI 1.8-15.57). This SNV is reported to be a splicing variant, negatively impacting CFH expression, and has previously been associated with Complement-driven renal disease. A second synonymous variant, rs61822181, was significantly less frequent in patients than in controls (p = 0.002; OR: 7.33; 95% CI 1.59-33.7), representing a protective factor against the development of leptospirosis. Our study represents the first documentation of the frequency of CFH SNVs in South America and identifies the variant rs34815383 T > C as a risk factor for leptospirosis and leptospirosis-related renal complications.

References

Anna A, Monika G . Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet. 2018; 59(3):253-268. PMC: 6060985. DOI: 10.1007/s13353-018-0444-7. View

Barbosa A, Abreu P, Vasconcellos S, Morais Z, Goncales A, Silva A . Immune evasion of leptospira species by acquisition of human complement regulator C4BP. Infect Immun. 2008; 77(3):1137-43. PMC: 2643629. DOI: 10.1128/IAI.01310-08. View

Barbosa A, Monaris D, Silva L, Morais Z, Vasconcellos S, Cianciarullo A . Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect Immun. 2010; 78(7):3207-16. PMC: 2897400. DOI: 10.1128/IAI.00279-10. View

Cedola M, Chiani Y, Pretre G, Alberdi L, Vanasco B, Gomez R . Association of Toll-like receptor 2 Arg753Gln and Toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an Argentine population. Acta Trop. 2015; 146:73-80. DOI: 10.1016/j.actatropica.2015.03.007. View

Clark S, Ridge L, Herbert A, Hakobyan S, Mulloy B, Lennon R . Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol. 2013; 190(5):2049-57. PMC: 3672945. DOI: 10.4049/jimmunol.1201751. View

Despriet D, Klaver C, Witteman J, Bergen A, Kardys I, de Maat M . Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006; 296(3):301-9. DOI: 10.1001/jama.296.3.301. View

Esteves L, Bulhoes S, Branco C, Mota F, Paiva C, Cabral R . Human leptospirosis: seroreactivity and genetic susceptibility in the population of São Miguel Island (Azores, Portugal). PLoS One. 2014; 9(9):e108534. PMC: 4177921. DOI: 10.1371/journal.pone.0108534. View

Fialho R, Martins L, Pinheiro J, Bettencourt B, Couto A, Santos M . Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis. Hum Immunol. 2009; 70(11):915-20. DOI: 10.1016/j.humimm.2009.08.007. View

Harrison R, Morikis D . Molecular Mechanisms of Macular Degeneration Associated with the Complement Factor H Y402H Mutation. Biophys J. 2019; 116(2):215-226. PMC: 6350009. DOI: 10.1016/j.bpj.2018.12.007. View

10.

Johnson R, MUSCHEL L . Antileptospiral activity of serum. I. Normal and immune serum. J Bacteriol. 1966; 91(4):1403-9. PMC: 316056. DOI: 10.1128/jb.91.4.1403-1409.1966. View

11.

Lingappa J, Kuffner T, Tappero J, Whitworth W, Mize A, Kaiser R . HLA-DQ6 and ingestion of contaminated water: possible gene-environment interaction in an outbreak of Leptospirosis. Genes Immun. 2004; 5(3):197-202. DOI: 10.1038/sj.gene.6364058. View

12.

Meri S, Morgan B, Davies A, Daniels R, Olavesen M, Waldmann H . Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology. 1990; 71(1):1-9. PMC: 1384213. View

13.

Osborne A, Breno M, Ghiringhelli Borsa N, Bu F, Fremeaux-Bacchi V, Gale D . Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. J Immunol. 2018; 200(7):2464-2478. PMC: 6324840. DOI: 10.4049/jimmunol.1701695. View

14.

Pangburn M, Schreiber R, MULLER-EBERHARD H . Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J Exp Med. 1977; 146(1):257-70. PMC: 2180748. DOI: 10.1084/jem.146.1.257. View

15.

Parente R, Clark S, Inforzato A, Day A . Complement factor H in host defense and immune evasion. Cell Mol Life Sci. 2016; 74(9):1605-1624. PMC: 5378756. DOI: 10.1007/s00018-016-2418-4. View

16.

Prosser B, Johnson S, Roversi P, Herbert A, Blaum B, Tyrrell J . Structural basis for complement factor H linked age-related macular degeneration. J Exp Med. 2007; 204(10):2277-83. PMC: 2118454. DOI: 10.1084/jem.20071069. View

17.

Richards A, Buddles M, Donne R, Kaplan B, Kirk E, Venning M . Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet. 2001; 68(2):485-90. PMC: 1235281. DOI: 10.1086/318203. View

18.

Ripoche J, Day A, Harris T, Sim R . The complete amino acid sequence of human complement factor H. Biochem J. 1988; 249(2):593-602. PMC: 1148743. DOI: 10.1042/bj2490593. View

19.

Zareparsi S, Branham K, Li M, Shah S, Klein R, Ott J . Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet. 2005; 77(1):149-53. PMC: 1226187. DOI: 10.1086/431426. View